Read the latest news from Saama.
CAMPBELL, Calif.–(BUSINESS WIRE)–Saama, a provider of AI-based solutions that accelerate clinical development and commercialization, today announced that it was named a Leader in the “Life
Suite of AI-enhanced SaaS solutions automates routine processes and provides a holistic view of trial operations and patient behaviors in real time.
CAMPBELL, Calif.–(BUSINESS WIRE)–Businesses quickly accumulate data, and often leave those records siloed instead of converging them into a critical asset that enables operations. According to
Partnership Set to Bolster Development Capabilities and Accelerate Pipeline Progress Outsourcing-Pharma provides more details and context around Saama’s multi-year partnership with Merck in this article
Saama Named Top 10 Most Recommended Solution Provider This feature in Healthcare Insights explains how Saama has become the “driving force behind the life science
CAMPBELL, CA – (August 10, 2022) – Saama Technologies, LLC. (“Saama”) today announced a multi-year agreement with Merck, known as MSD outside the United States
Getting Ready for AI in Clinical Trials This recap of a presentation by Malaikannan Sankarasubbu, VP of AI Research at Saama; Aamir Jaka, Saama’s VP
Bringing Treatments to Patients Faster by Democratizing ClinTech The Silicon Review talked with Suresh Katta, Saama’s Chairman Emeritus, about using artificial intelligence (AI) and other
Saama Appoints Scott Rogers as Company’s Chief Financial Officer Scott brings a unique combination of financial and clinical fused with growth experience to Saama New
